Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Apr;30(4):511-9.
doi: 10.1002/humu.20828.

Mutations and polymorphisms in GUSB gene in mucopolysaccharidosis VII (Sly Syndrome)

Shunji Tomatsu  1 , Adriana M Montaño, Vu Chi Dung, Jeffrey H Grubb, William S Sly
Affiliations
Review

Mutations and polymorphisms in GUSB gene in mucopolysaccharidosis VII (Sly Syndrome)

Shunji Tomatsu et al. Hum Mutat. 2009 Apr.

Abstract

Mucopolysaccharidosis VII (MPS VII; Sly syndrome) is an autosomal recessive disorder caused by a deficiency of beta-glucuronidase (GUS, EC 3.2.1.31; GUSB). GUS is required to degrade glycosaminoglycans (GAGs), including heparan sulfate (HS), dermatan sulfate (DS), and chondroitin-4,6-sulfate (CS). Accumulation of undegraded GAGs in lysosomes of affected tissues leads to mental retardation, short stature, hepatosplenomegaly, bone dysplasia, and hydrops fetalis. We summarize information on the 49 unique, disease-causing mutations determined so far in the GUS gene, including nine novel mutations (eight missense and one splice-site). This heterogeneity in GUS gene mutations contributes to the extensive clinical variability among patients with MPS VII. One pseudodeficiency allele, one polymorphism causing an amino acid change, and one silent variant in the coding region are also described. Among the 103 analyzed mutant alleles, missense mutations accounted for 78.6%; nonsense mutations, 12.6%; deletions, 5.8%; and splice-site mutations, 2.9%. Transitional mutations at CpG dinucleotides made up 40.8% of all the described mutations. The five most frequent mutations (accounting for 44/103 alleles) were exonic point mutations, p.L176F, p.R357X, p.P408S, p.P415L, and p.A619 V. Genotype/phenotype correlation was attempted by correlating the effects of certain missense mutations or enzyme activity and stability within phenotypes. These were in turn correlated with the location of the mutation in the tertiary structure of GUS. A total of seven murine, one feline, and one canine model of MPS VII have been characterized for phenotype and genotype.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Location of GUS gene mutations in MPS VII patients. The exons are presented by open boxes and the untranslated regions are filled boxes. Clinical phenotypes associated with missense or nonsense mutations are described.
Figure 2
Figure 2
Multiple amino acid alignment of GUS from human (Hosa-GUS), chimpanzee (Patr-GUS), cow (Bota-GUS), pig (Susc-GUS), dog (Cafa-GUS), mouse (Mumu-GUS), rat (Rano-GUS), chicken (Gaga-GUS), frog (Xetr-GUS), fruit fly (Drme-GUS), mosquito (Anga-GUS), honey bee (Apme-GUS), red flour beetle (Trca-GUS), nematode (Cael-GUS), gram-positive bacteria (Arsp.-GUS), enterobacteria (Esco-GUS), and fungi (Scsp.-GUS), along with bacterial β-galactosidase (Esco-β-Gal). The arrow indicates the active site (residue E540) of human GUS. GenBank reference sequences: Homo sapiens, NM_010368.1, NP_034498.1; Pan troglodytes, XP_001138789.1; Macaca mulata, XM_001087699; Mus musculus, NM_010368.1, NP_034498.1; Rattus norvegicus, NP_058711; Felis catus, NM_001009310.1, NP_001009310.1; Canis familiaris, NM_001003191.1, NP_001003191.1; Bos taurus, NM_001083436.1; Sus scrofa, AK232674.1; Gallus gallus, NP_001034405; Xenopus tropicalis, CT030620; Danio renio, XM_695030; Drosophila melanogaster, NP_001014535.1; Anopheles gambiae, XP_320660.2; Apis mellifera, XM_393305; Tribolium castaneum, XM_964260.1; Caenorhabditis elegans, NP_493548.1; Arthrobacter sp., RP10, AAV91790; Scopulariopsis sp., RP38.3, AAV91788; Escherichia coli, AAB30197.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Antonarakis SE, Krawczak M, Cooper DN. The nature and mechanisms of human gene mutation. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. McGraw-Hill; New York: 2001. pp. 343–377.
    1. Birkenmeier EH, Davisson MT, Beamer WG, Ganschow RE, Vogler CA, Gwynn B, Lyford KA, Maltais LM, Wawrzyniak CJ. Murine mucopolysaccharidosis type VII. Characterization of a mouse with beta-glucuronidase deficiency. J Clin Invest. 1989;83:1258–1266. - PMC - PubMed
    1. Brot FE, Bell CE, Jr, Sly WS. Purification and properties of beta-glucuronidase from human placenta. Biochemistry. 1978;17:385–391. - PubMed
    1. Fukuda S, Tomatsu S, Sukegawa K, Sasaki T, Yamada Y, Kuwahara T, Okamoto H, Ikedo Y, Yamaguchi S, Orii T. Molecular analysis of mucopolysaccharidosis type VII. J Inherit Metab Dis. 1991;14:800–804. - PubMed
    1. Fyfe JC, Kurzhals RL, Lassaline ME, Henthorn PS, Alur PR, Wang P, Wolfe JH, Giger U, Haskins ME, Patterson DF, Sun H, Jain S, Yuhki N. Molecular basis of feline beta-glucuronidase deficiency: an animal model of mucopolysaccharidosis VII. Genomics. 1999;58:121–128. - PubMed

Publication types